This blog series provides regular updates on new pharmaceutical products approved, new indications, and any other relevant changes. The new therapies in the list below may ultimately lead to new guideline updates in the future. You can find the recap or notable FDA drug changes (AdCom, PDUFDA, etc.) for July – September 2020 below. If Read More

It’s been quite some time since the last clinical guideline pipeline update, so let’s run down what clinical practice guidelines updated or published between January – September 2020. While we strive for completeness, it’s possible we may miss a few guidelines. If your organization has a guideline not on this list, please contact us so Read More

It has been quite a while since our last update, so this is a big one! As a reminder, this is a continuation of our new blog series to update you on recent FDA drug approvals, new indications, and other changes. You can find the recap or notable FDA drug changes (AdCom, PDUFDA, etc.) for Read More

Later this year Guideline Central will be releasing the next evolution of our guidelines-based decision-support platform. We expect to launch sometime in Q2, and it will be our most signifcant evolution yet. Some of the new features and enhancements to expect: new interfaces for finding, referencing and implementing guidelines recommendation-level searching and filtering advanced search Read More

Let’s run down what clinical practice guidelines updated or published in Q4 2019. While we strive for completeness, it’s possible we may miss a few guidelines. If your organization has a guideline not on this list, please contact us so that we can add it. Also make sure to check out our recent post for Read More

This is a continuation of our new blog series to update you on recent FDA drug approvals, new indications, and other changes! You can find the recap or notable FDA drug changes (AdCom, PDUFDA, etc.) for November and December 2019 below. If we are missing information or you’d like more information about one of the Read More

This is a continuation of our new blog series to update you on recent FDA drug approvals, new indications, and other changes! You can find the recap or notable FDA drug changes (AdCom, PDUFDA, etc.) for September and October 2019 below. If we are missing information or you’d like more information about one of the Read More

Let’s run down what clinical practice guidelines updated or published in Q3 2019 and which ones are slated to release in the third quarter. While we strive for completeness, it’s possible we may miss a few guidelines. If your organization has a guideline not on this list, or if there’s an “upcoming” guidelines for our Read More

We’re starting a new blog series to update you on recent FDA drug approvals, new indications, and other changes! You can find the recap or notable FDA drug changes for August 2019 below. If we are missing information or you’d like more information about one of the noted changes, feel free to contact us. Product Read More

The organization previously known as Institute of Medicine (IOM), now known as The National Academy of Medicine (NAM), released standards for systematic reviews in March of 2011. Since its release, these 2011 IOM Standards (now 2011 NAM Standards) have been the bar in which many organizations and guideline developers operate by when creating guidelines. While Read More